2-Chloroephenidine
2-Chloroephenidine is a dissociative research chemical of the diarylethylamine class and a structural analogue of ephenidine. Very little is known about this compound's pharmacology, toxicity, or subjective effect profile.1 It is believed to produce dissociative effects and is reported to be slightly less potent than its parent compound. Due to the near-total absence of research or documented human use, it should be approached with extreme caution.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Very little is documented about this compound. As a structural analogue of ephenidine, it is considered likely to produce dissociative effects, with slightly lower potency than the parent compound.
Pharmacology
Pharmacodynamics
Pharmacokinetics
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Dissociatives, NMDA receptor antagonists
Harm Potential
History & Culture
Legality
International
As of 23 August 2026, 2-Chloroephenidine (2-(2-chlorophenyl)-N-ethyl-1-phenylethylamine) is not named or chemically designated in the current complete INCB Yellow, Green or Red Lists. The Green List instead places diphenidine, chemically designated as 1-(1,2-Diphenylethyl)piperidine, in Schedule II. That entry does not cover 2-Chloroephenidine: diphenidine contains a piperidine ring, while 2-Chloroephenidine is an open-chain N-ethylamine with an ortho-chloro substituent. The Green List's stereoisomer guidance applies within the specific chemical designation of a scheduled substance, not to constitutionally distinct analogues. INCB's March 2026 notice adds only MDMB-FUBINACA to Schedule II, with effect from 25 November 2026, and does not name 2-Chloroephenidine. Accordingly, the current INCB materials establish no scheduling of 2-Chloroephenidine under the 1961, 1971 or 1988 conventions.
By Country
References
Source Pages
Citations
- 2-Chloro-Ephenidine. Chemical Route (n.d.). https://chemicalroute.com/product/2-chloro-ephenidine/1
- Decreto 560/2019, artículo 2 y Anexo II (Grupo 15: Fenetilaminas sustituidas). argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/decreto-560-2019-326675/actualizacion1
- Decreto 560/2019, artículo 2 y Anexo II (Grupo 15: Fenetilaminas sustituidas). argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/326675_dec560-2_pdf/archivo1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, section 7 and Schedule 9. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2026L00633/asmade/2026-05-28/text/original/epub/OEBPS/document_1/document_1.html1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, section 7 and Schedule 9. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2024L01228/asmade/2024-09-30/es/original/epub/OEBPS/document_1/document_1.html1
- Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026, section 7 and Schedule 9. pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/compound/434890921
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), § 1 Abs. 1 Z 2 and Abs. 2, Anlage II Z 2; Neue-Psychoaktive-Substanzen-Gesetz (NPSG), § 4. ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2024_II_106/Anlagen_0001_BA9813D3_0B74_48C4_93B4_C711A2708880.pdf1
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), § 1 Abs. 1 Z 2 and Abs. 2, Anlage II Z 2; Neue-Psychoaktive-Substanzen-Gesetz (NPSG), § 4. ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/ii/2011/468/P1/NOR401871781
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), § 1 Abs. 1 Z 2 and Abs. 2, Anlage II Z 2; Neue-Psychoaktive-Substanzen-Gesetz (NPSG), § 4. ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/i/2011/146/P4/NOR401344471
- Neue-Psychoaktive-Substanzen-Verordnung (NPSV), § 1 Abs. 1 Z 2 and Abs. 2, Anlage II Z 2; Neue-Psychoaktive-Substanzen-Gesetz (NPSG), § 4. drugs.ncats.io (n.d.). https://drugs.ncats.io/drug/H6G56R5EWK12345
- Portaria SVS/MS nº 344/1998, Anexo I, Lista F2, item a(100) and Adendo 1.1, as republished by RDC Anvisa nº 1.036/2026. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/UrlPublicasAction.php?acao=abrirAtoPublico&num_ato=00001036&sgl_tipo=RDC&sgl_orgao=RDC/DC/ANVISA/MS&vlr_ano=2026&seq_ato=000&cod_modulo=134&cod_menu=16961
- Portaria SVS/MS nº 344/1998, Anexo I, Lista F2, item a(100) and Adendo 1.1, as republished by RDC Anvisa nº 1.036/2026. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista-substancias1
- Portaria SVS/MS nº 344/1998, Anexo I, Lista F2, item a(100) and Adendo 1.1, as republished by RDC Anvisa nº 1.036/2026. drugs.ncats.io (n.d.). https://drugs.ncats.io/drug/4A5352XI2A1
- Controlled Drugs and Substances Act, Schedule I, item 24. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), section 3 and Annex 1 group 1. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/anlage_1.html1
- Neue-psychoaktive-Stoffe-Gesetz (NpSG), section 3 and Annex 1 group 1. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/npsg/__3.html1
- Opium Act, article 2a and List IA group 1, as inserted by Staatsblad 2025, 32. zoek.officielebekendmakingen.nl (n.d.). https://zoek.officielebekendmakingen.nl/stb-2025-32.html1
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, załącznik nr 3 część 2 (Dz.U. 2024 poz. 1139, as amended by Dz.U. 2025 poz. 598 and Dz.U. 2026 poz. 934). eli.gov.pl (n.d.). https://eli.gov.pl/api/acts/DU/2024/1139/text.html1
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, załącznik nr 3 część 2 (Dz.U. 2024 poz. 1139, as amended by Dz.U. 2025 poz. 598 and Dz.U. 2026 poz. 934). eli.gov.pl (n.d.). https://eli.gov.pl/eli/DU/2025/598/ogl1
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, załącznik nr 3 część 2 (Dz.U. 2024 poz. 1139, as amended by Dz.U. 2025 poz. 598 and Dz.U. 2026 poz. 934). eli.gov.pl (n.d.). https://eli.gov.pl/eli/DU/2026/934/ogl1
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, załącznik nr 3 część 2 (Dz.U. 2024 poz. 1139, as amended by Dz.U. 2025 poz. 598 and Dz.U. 2026 poz. 934). api.sejm.gov.pl (n.d.). https://api.sejm.gov.pl/eli/acts/DU/2023/1939/text.html1
- Resolution of the Government of the Russian Federation No. 681 of 30 June 1998, List I (as amended through Resolution No. 880 of 11 June 2025). eec.eaeunion.org (n.d.). https://eec.eaeunion.org/upload/medialibrary/ce5/jxs8zar8pwnvwhjinle1v2k0o4u2i77h/Drugs_RU_2025.pdf1
- Resolution of the Government of the Russian Federation No. 681 of 30 June 1998, List I (as amended through Resolution No. 880 of 11 June 2025). denmark.kdmid.ru (n.d.). https://denmark.kdmid.ru/documents/Perechen-narkoticheskih-sredstv-i-psihotropnih-veschestv.pdf1
- Misuse of Drugs Act 1973, sections 2 and 11I. policija.si (n.d.). https://www.policija.si/images/stories/GPUNFL/PDF/P-054_Prague2015_NPS_Poster_EAFS2015.pdf1
- Misuse of Drugs Act 1973, sections 2 and 11I. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/Act/MDA1973?ProvIds=Sc1-&ValidDate=202606011
- Misuse of Drugs Act 1973, sections 2 and 11I. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/Act/MDA1973?ProvIds=pr2-&ValidDate=202606011
- Misuse of Drugs Act 1973, sections 2 and 11I. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/Act/MDA1973?ProvIds=Sc5-&ValidDate=202606011
- Misuse of Drugs Act 1973, sections 2 and 11I. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/Act/MDA1973?ProvIds=pr11I-&ValidDate=202606011
- Misuse of Drugs Act 1973, sections 2 and 11I. cnb.gov.sg (n.d.). https://www.cnb.gov.sg/singapore-drug-situation/drugs--psychoactive-substances--and-inhalants/new-pyschoactive-substances/1
- Misuse of Drugs Act 1973, sections 2 and 11I. mha.gov.sg (n.d.). https://www.mha.gov.sg/media-room/newsroom/commencement-of-the-misuse-of-drugs-amendment-act-2023-second-tranche-and-constitution-of-the-republic-of-singapore-amendment-act-2023/1
- Psychoactive Substances Act 2016, sections 2 and 5. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/2016/2/section/21
- Psychoactive Substances Act 2016, sections 2 and 5. legislation.gov.uk (n.d.). https://www.legislation.gov.uk/ukpga/2016/2/section/51
Further Reading
Enantiomeric separation of diphenidine derivatives (J Chromatogr B 2025)
French Addictovigilance Network – phenidine complications (2019)
Journal of Psychopharmacology - Pharmacological investigations of diphenidine analogues (2016)
NCATS Inxight entry – 2-Chloro-ephenidine
Nervewing: Diarylethylamines overview (2020)
Pharmacological investigations of diphenidine analogues (J Psychopharmacol 2016)
PLOS ONE - Pharmacological Investigations of Dissociative 'Legal Highs' (2016)
PubChem: 2 Chloro ephenidine
Receptor-binding heat-map of diarylethylamines (2016)
Reddit: r/researchchemicals binding-affinity thread (2023)
Structure–activity summary of diarylethylamines (ResearchGate 2024)
UK ACMD - Diphenidine diarylethylamine review (2023)
UK ACMD diarylethylamine report (2023)
Wiley NPS laboratory testing review (2023)
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the 2-Chloroephenidine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.
